Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 293
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01685411 | Busulfan and Cyclophosphamide Followed By ALLO BMT | ||
| NCT00005998 | Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease | ||
| NCT05705700 | Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP) | ||
| NCT04466098 | Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19) | ||
| NCT01385423 | Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML) | ||
| NCT03946423 | BAriaTric Surgery After Breast Cancer Treatment (BATS) | ||
| NCT02179359 | Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies | ||
| NCT00602446 | Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant | ||
| NCT00005986 | Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia | ||
| NCT02845414 | Study of CD133KDEL Toxin in the Treatment for Solid Tumors | ||
| NCT03314974 | Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders | ||
| NCT02370160 | HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma | ||
| NCT03642626 | MT2017-45: CAR-T Cell Therapy for Heme Malignancies | ||
| NCT01681875 | Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes | ||
| NCT01009437 | Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer | ||
| NCT00703638 | Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors | ||
| NCT00177047 | Autologous Transplant for Multiple Myeloma | ||
| NCT06544811 | American Indian Smokefree Native RCT | ||
| NCT06342986 | Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer | ||
| NCT00379197 | Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer | ||
| NCT00287859 | Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | ||
| NCT00176904 | Stem Cell Transplant for Inborn Errors of Metabolism | ||
| NCT03978117 | Clinical Trial of Two Study Drinks in Detoxification of Environmental Toxicants and Carcinogens | ||
| NCT03998735 | Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure | ||
| NCT00095160 | Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors | ||
| NCT06295757 | Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures | ||
| NCT00006451 | Bone Marrow Transplantation in Treating Patients With Leukemia | ||
| NCT03125642 | Auto Stem Cell Transplant for Lymphoma Patients | ||
| NCT04630769 | FT516 and IL2 With Enoblituzumab for Ovarian Cancer | ||
| NCT04105270 | RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial | ||
| NCT00784524 | Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca | ||
| NCT06030648 | MT2022-01: MSCs for ALD | ||
| NCT00400803 | Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer | ||
| NCT00176878 | Stem Cell Transplant for Bone Marrow Failure Syndromes | ||
| NCT00005987 | Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma | ||
| NCT03383055 | CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig | ||
| NCT01106950 | Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML) | ||
| NCT03421678 | Ethnic/Racial Differences in Metabolism and DNA Adduct Formation | ||
| NCT04055844 | Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS | ||
| NCT00652899 | Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer | ||
| NCT05114837 | Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL | ||
| NCT01526603 | High Dose Chemotherapy and Autologous Transplant for Neuroblastoma | ||
| NCT07560865 | First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma | ||
| NCT02999399 | Glucobrassicin-Brussel Sprout Effect on D10 Phe Metabolism | ||
| NCT01181258 | Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies | ||
| NCT01173016 | Administration of IV Laronidase Post Bone Marrow Transplant in Hurler | ||
| NCT06792825 | HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL | ||
| NCT02605421 | Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma | ||
| NCT06213298 | Effect of Kava on Anxiety and Stress in Cancer Survivors | ||
| NCT00281827 | Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer |
